• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    36.13 Down 0.44(1.20%) Apr 17, 4:00PM EDT
    |After Hours : 37.00 Up 0.87 (2.41%) Apr 17, 6:10PM EDT
    Add to Portfolio
    Prev Close:36.57
    Open:36.52
    Bid:36.13 x 100
    Ask:39.00 x 1000
    1y Target Est:42.60
    Beta:2.36
    Next Earnings Date:30-Apr-15SGEN Earnings announcement
    Day's Range:35.93 - 36.86
    52wk Range:30.05 - 44.95
    Volume:1,180,863
    Avg Vol (3m):1,113,000
    Market Cap:4.49B
    P/E (ttm):N/A
    EPS (ttm):-0.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 1.20%4.49B
    IMGNUp 0.40%871.40M
    PFEDown 0.43%214.76B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.71
    Quarterly EPS Est (Mar-15) :-0.19
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-2.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback